Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Cuitang Granules for the treatment of common cold
ChiCTR1800019836Phase 3Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Cuitang granules in nasopharyngitis (3 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: 24-hour antipyretic rate. Started Jan 2018; status: recruiting.
02
Drugs
Cuitang granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ChiCTR1800019836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019836.